DoctoRx

Special situations, growth at reasonable price, value, micro-cap
DoctoRx
Special situations, growth at reasonable price, value, micro-cap
Contributor since: 2013
12/22/14
DoctoRx
Abbvie Versus Gilead In Hepatitis C, With Comments On Biotech $GILD http://seekingalpha.com/a/1nfwj
12/16/14
DoctoRx
Deflation Now? If So, Cash Is No Longer Trash: Discussion And Implications http://seekingalpha.com/a/1n4wf
12/11/14
DoctoRx
Investing And Trading Implications Of The Great Oil Bust Of 2014: Time To Buy The Dip? http://seekingalpha.com/a/1mxiv
12/9/14
DoctoRx
Still Bullish On Bonds: Analysis And A Forecast http://seekingalpha.com/a/1ms1n
12/4/14
DoctoRx
My Bearish Views On Oil Prices Prove Accurate: What Next? http://seekingalpha.com/a/1mj2l
Never recovered from '05. Much more left to fall.
11/26/14
DoctoRx
Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs $AMGN http://seekingalpha.com/a/1m39z
11/6/14
DoctoRx
Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis $REGN http://seekingalpha.com/a/1kmi9
11/4/14
DoctoRx
Is AbbVie's Bullishness On Its Hepatitis C Drugs Valid? $GILD http://seekingalpha.com/a/1kdp1
10/30/14
DoctoRx
United Therapeutics Sells Off On Good News - Why I Bought That Dip $UTHR http://seekingalpha.com/a/1jzrn
10/30/14
DoctoRx
Gilead Beats And (Sort Of) Raises, Stock Drops: What Gives? $GILD http://seekingalpha.com/a/1jxrz
10/23/14
DoctoRx
Amgen And Regeneron Reach All-Time Highs Together: Updates On Both Biotech Stalwarts $AMGN http://seekingalpha.com/a/1jgnl
10/15/14
DoctoRx
A Review Of Gilead's Harvoni, And Competitive Considerations $GILD http://seekingalpha.com/a/1iy7f
10/15/14
DoctoRx
Why I'm Not Buying The Dip In Domestic Energy Stocks $TRN http://seekingalpha.com/a/1ixxp
10/13/14
DoctoRx
Additional Bullish Portents For Treasuries $TLT http://seekingalpha.com/a/1iu7t
10/9/14
DoctoRx
'Bullish On Bonds' - An Update $TLT http://seekingalpha.com/a/1invh
10/6/14
DoctoRx
Update: Portola Reports Positive Phase 3 Results And A Secondary Stock Offering $PTLA http://seekingalpha.com/a/1iioj
10/3/14
DoctoRx
The Importance Of TAF To Gilead $GILD http://seekingalpha.com/a/1if65
9/26/14
DoctoRx
That Was The Week That Was For Gilead, And It Was Another Good To Great One $GILD http://seekingalpha.com/p/1ytkl
9/17/14
DoctoRx
GIlead's Simtuzumab Fails For Cancer $GILD http://seekingalpha.com/p/1y5f5
9/17/14
Like your analysis on this news,
9/17/14
I'm very surprised to see the drop this am based on this news..may add $GILD again today :)
9/8/14
DoctoRx
Gilead Update: Good News Keeps On Coming; Much Higher Share Prices Appear Justified $GILD http://seekingalpha.com/a/1h4i5
9/8/14
DoctoRx
Challenging Consensus On PCSK9 Inhibitors: Focus On Regeneron And Amgen $REGN http://seekingalpha.com/a/1h4fn
8/26/14
DoctoRx
Why I Bought Into Monday's Move In Regeneron $REGN http://seekingalpha.com/a/1gjh7
8/28/14
for some reason I cannot read the comments, cannot add either - anyone else have this problem?
8/25/14
DoctoRx
The Taper Of QE, And Other Reasons To Be Bullish On Bonds http://seekingalpha.com/a/1gif5
8/22/14
DoctoRx
8/15/14
DoctoRx
Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock $GILD http://seekingalpha.com/a/1g16l
8/15/14
DoctoRx
Supernus Finding Success, Looks Undervalued $SUPN http://seekingalpha.com/a/1fx6z
8/12/14
DoctoRx
United Therapeutics: A Low P/E Biotech With Potential For Further Rapid Growth $UTHR http://seekingalpha.com/a/1fn8n
8/29/14
read your article in holiday and i forgot to take a position when i got back home :( today +26%
8/8/14
DoctoRx
The Case That Regeneron May Be Significantly Undervalued $REGN http://seekingalpha.com/a/1fh1v
7/30/14
DoctoRx
The Case That Our Investment Dollars Will Be Treated Well In Dollar Tree Stock $DLTR http://seekingalpha.com/a/1ekuz
7/29/14
DoctoRx
Gilead Sciences Price Target Update $GILD http://seekingalpha.com/p/1ulvr
7/24/14
DoctoRx
A Re-Analysis Of Gilead After Q2 Results And The Early Idelalisib Approval $GILD http://seekingalpha.com/a/1e4m9
7/23/14
DoctoRx
Biogen Idec Beats And Raises: Reassessing Its Prospects $BIIB http://seekingalpha.com/a/1e1cr